Skip to main content

Day: April 28, 2025

Piedmont Office Realty Trust, Inc. Releases First Quarter 2025 Results

Atlanta, April 28, 2025 (GLOBE NEWSWIRE) — Piedmont Office Realty Trust, Inc (NYSE: PDM) has released its financial and operational results for the first quarter of 2025.  Please visit the Investor Relations section of Piedmont’s website at https://investor.piedmontreit.com to access the Earnings Release and Supplemental Information. Piedmont has scheduled a conference call and an audio web cast for Tuesday, April 29, 2025, at 9:00 A.M. Eastern time. The live, listen-only, audio web cast of the call may be accessed on the Company’s website at https://investor.piedmontreit.com/news-and-events/events-calendar. Dial-in numbers for analysts who plan to actively participate in the call are (888) 506-0062 for participants in the United States and Canada and (973) 528-0011 for international participants. Participant Access...

Continue reading

NXP Semiconductors Reports First Quarter 2025 Results, Announces Management Transition

EINDHOVEN, The Netherlands, April 28, 2025 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the first quarter, which ended March 30, 2025. “NXP delivered quarterly revenue of $2.84 billion, in-line with the midpoint of guidance. NXP’s first-quarter results and guidance for the second quarter underpin a cautious optimism that NXP continues to effectively navigate through a challenging set of market conditions. We are operating in a very uncertain environment influenced by tariffs with volatile direct and indirect effects. Considering these external factors, we are redoubling our efforts to manage what is in our direct control, enabling NXP to drive solid profitability and earnings,” said Kurt Sievers, NXP President and Chief Executive Officer. The company announced that Mr. Sievers...

Continue reading

EZCORP Reports Second Quarter Fiscal 2025 Results

Record Q2 PLO & Revenues Drive Strong Increase in Profitability AUSTIN, Texas, April 28, 2025 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, today announced results for its second quarter ended March 31, 2025. Unless otherwise noted, all amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”) and comparisons shown are to the same period in the prior year. SECOND QUARTER HIGHLIGHTSPawn loans outstanding (PLO) up 11% to $261.8 million.Net income increased 18% to $25.4 million. On an adjusted basis1, net income increased 25% to $26.1 million.Diluted earnings per share increased 14% to $0.33. On an adjusted basis, diluted earnings per share increased 21% to $0.34.Adjusted EBITDA increased 23%...

Continue reading

Results of Operations for the Year Ended December 31, 2024 – American Overseas Group Limited Announces Net Income Of $9.4 Million For the Year Ended December 31, 2024

HAMILTON, Bermuda, April 28, 2025 (GLOBE NEWSWIRE) — American Overseas Group Limited (BSX: AORE.BH) (Pink Sheets: AOREF.PK) (“AOG” or the “Company”) today reported consolidated net income available to common shareholders of $9.4 million, or $200.09 per diluted share, for the year ended December 31, 2024. This compares to consolidated net income available to common shareholders of $5.3 million, or $113.56 per diluted share, for the year ended December 31, 2023. Book value per weighted share at December 31, 2024 was $976.60, an increase from the book value per weighted share of $772.67 at December 31, 2023. For the three months ended December 31, 2024, net earned property and casualty premiums increased $5.1 million from $9.2 million a year ago to $14.3 million. For the year ended December 31, 2024, net earned property and casualty...

Continue reading

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived, cell-based allogeneic immunotherapies without engaging in separate activities such as contract manufacturing, contract research, medical device development, or diagnostics, today announced its full-year ended December 31, 2024 financial results and provided clinical and corporate updates. We intend to be among the early pioneers of cellular immunotherapy treatment modalities to serve the ASEAN region and North Asia with a population of more than two billion. Capitalizing on Asia’s low-cost infrastructure and talents, we make affordable GMP-grade immune cells to...

Continue reading

Financial Institutions, Inc. Announces First Quarter 2025 Results

WARSAW, N.Y., April 28, 2025 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ: FISI) (the “Company,” “we” or “us”), parent company of Five Star Bank (the “Bank”) and Courier Capital, LLC (“Courier Capital”), today reported financial and operational results for the first quarter ended March 31, 2025. The Company reported net income of $16.9 million in the first quarter of 2025, compared to a net loss of $82.8 million in the fourth quarter of 2024 and net income of $2.1 million in the first quarter of 2024. After preferred dividends, net income available to common shareholders was $16.5 million, or $0.81 per diluted share, in the first quarter of 2025, compared to net loss of $83.2 million, or $(5.07) per diluted share, in the fourth quarter of 2024, and net income...

Continue reading

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth Quarter 2024 Financial Highlights (Comparatives Exclude Discontinued STEM Animal Health “STEM” Operations):Total revenue for the three months ended December 31,2024 was $125,859 compared to $57,788 in the three months ended December 31, 2023. Fourth quarter revenue consists primarily of contract animal health manufacturing revenue for Dechra Veterinary Products, Inc. Gross loss for the fourth quarter of 2024 was $(87,204), compared to a gross profit of $34,300 for the fourth quarter of 2023. During the quarter, the Company recorded $209,775 in inventory write-downs primarily associated with its DermaKBTM product...

Continue reading

HII’s Ingalls Shipbuilding Honored with Mississippi Governor’s Initiative for Volunteer Excellence Award

PASCAGOULA, Miss., April 28, 2025 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division was recognized Thursday with a 2025 Governor’s Initiative for Volunteer Excellence (GIVE) award presented by Volunteer Mississippi in partnership with the Office of the Mississippi Governor. Ingalls received the corporate volunteering champion award, which recognizes private sector corporations and small businesses that implement employee volunteer programs with demonstrable community impact and that set community service as a core value and business strategy. “Volunteerism is part of our identity at Ingalls and we are proud to have our shipbuilders making a contribution every day to our local communities,” said Lisa Bradley, community relations manager at Ingalls Shipbuilding. “This award is a testament to our shipbuilders’ dedication...

Continue reading

VINCI successfully places a tap issue of non-dilutive convertible bonds for €150 million to be fully assimilated to its €400 million non-dilutive convertible bonds due February 2030

Nanterre, 28 April 2025 VINCI successfully places a tap issue of non-dilutive convertible bonds for €150 million to be fully assimilated to its €400 million non-dilutive convertible bonds due February 2030 VINCI announces today the successful placement of a tap issue of non-dilutive convertible bonds for a nominal amount of €150 million (the “New Bonds”). The transaction is non-dilutive due to the simultaneous purchase by VINCI of mirroring call options on its own shares. Following investors’ demand, the initial amount of the tap issue of €125 million has been increased to €150 million. The New Bonds are to be issued on the same terms (save for the issue price) as the €400 million non-dilutive convertible bonds due 18 February 2030 issued by Vinci on 18 February 2025 (the “Original Bonds”, together with the Original Bonds, the “Bonds”)...

Continue reading

Faculty Group and Ghaf Capital Announce Strategic Merger to Launch Web3 Powerhouse, Ghaf Group

DUBAI, United Arab Emirates, April 28, 2025 (GLOBE NEWSWIRE) — In a landmark move, Faculty Group and Ghaf Capital today announced their merger to form Ghaf Group, a vertically integrated Web3 advisory business. This strategic union leverages Faculty Group’s full-stack Web3 execution capabilities alongside Ghaf Capital’s elite access to capital markets, sovereign networks, and strategic enterprise relationships across the MENA region and beyond. With operations spanning capital allocation, product development, token advisory, liquidity management and marketing, Ghaf Group is uniquely positioned to drive the next wave of blockchain and Web3 growth. The new entity unites over 100 experts across eight subsidiaries under a single, scalable platform committed to delivering institutional-grade solutions and unlocking long-term value...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.